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Abstract
Objective: Both osteoporosis and cardiovascular disease (CVD) are diseases that comprise a growing medical and economic
burden in ageing populations. They share many risk factors, including ageing, low phy-sical activity, and possibly
overweight. We aimed to study associations between individual risk factors for CVD and bone mineral density (BMD) and
turnover markers (BTMs) in apparently healthy cohort.
Design: A cross-sectional assessment of 155 healthy 32-year-old adults (74 males) was performed for skeletal status, CVD
risk factors and lifestyle factors.
Methods: We analysed serum osteocalcin, procollagen I aminoterminal propeptide (P1NP), collagen I carboxy-terminal
telopeptide (ICTP) and urine collagen I aminoterminal telopeptide (U-NTX), as well as serum insulin, plasma glucose,
triglyceride and HDL-cholesterol levels. BMD, fat and lean mass were asses-sed using DXA scanning. Associations were
tested with partial correlations in crude and adjusted mo-dels. Bone status was compared between men with or without
metabolic syndrome (defined according to the NCEP-ATPIII criteria) with multivariate analysis.
Results: Osteocalcin and P1NP correlated inversely with insulin (R =20.243, P = 0.003 and R=20.187, P = 0.021) and glucose
(R =20.213, P = 0.009 and R=20.190, P = 0.019), but after controlling for fat mass and lifestyle factors, the associations
attenuated with insulin (R =20.162, P = 0.053 and R=20.093, P = 0.266) and with glucose (R =20.099, P = 0.240 and R=2
0.133, P = 0.110), respectively. Whole body BMD associated in-versely only with triglycerides in fully adjusted model. In men
with metabolic syndrome, whole body BMD, osteocalcin and P1NP were lower compared to healthy men, but these findings
disappeared in fully adjusted model.
Conclusions: In young adults, inverse associations between BTM/BMD and risk factors of CVD appeared in crude models,
but after adjusting for fat mass, no association continued to be present. In addition to fat mass, lifestyle factors, especially
physical activity, modified the associations between CVD and bone charac-teristics. Prospective studies are needed to
specify the role of mediators and lifestyle factors in the prevention of CVD and osteoporosis.
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Introduction
Both osteoporosis and cardiovascular disease (CVD) are
degenerative diseases that comprise an increasing medical and
economic burden in ageing populations. Association between these
conditions suggest shared pathophysiology [1], shared risk factors
[2] or causality [1]. Understanding these is meaningful for the
prevention and treatment of these disorders.
Bone compartment is a part of the body composition with a
strong correlation with lean mass. Body composition can be
assessed accurately with dual energy x-ray absorptiometry (DXA)
and bone mineral density (BMD) surrogates a long-term bone
status, while circulating bone turnover markers (BTMs) describe
the current bone remodelling phase. Other determinants of BMD
include physical activity, smoking and dietary intake of calcium
and vitamin D. Central adiposity is a key hallmark in the
development of metabolic syndrome, which is characterised by a
clustering of risk factors (impaired glucose tolerance, unfavourable
lipid profile, elevated blood pressure and low grade inflammation)
for CVD and type 2 diabetes [3]. On the other hand, central
adiposity is linked to inferior bone quality and altered bone
turnover, as assessed in bone biopsies in premenopausal women
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[4]. An association between metabolic syndrome and osteoporosis
is conflicting and biased by age, gender, menopausal status, obesity
and ethnicity [5–8]. In addition, no proof of a causal relationship
between metabolic syndrome and osteoporosis has been reported.
Our aim was, first, to study the associations between individual
risk factors of CVD and bone characteristics (BMD and BTMs) in
a cohort of 32-year-old apparently healthy men and women.
Second, we explored the role of lifestyle factors as modifiers of this
association. At the age of 32 years, peak bone mass [9] is still
maintained and only a few risk factors for CVD [10] may have
emerged, and accordingly, pathophysiology could be explored in
an unbiased setting.
Subjects and Methods
Ethics Statement
The study was approved by the Ethics Committee of the
Helsinki and Uusimaa Hospital District in Helsinki, Finland.
Written informed consent was obtained from all participants.
Subjects
This study cohort was part of a prospective evaluation of the
impact of early infant feeding pattern on adult bone health, body
composition, metabolic features and cardiovascular health [9–11].
The original study cohort consisted of 238 healthy full-term
Finnish newborns with a birth weight over 3,000 g, born in 1975
at the Helsinki University Central Hospital [12,13]. At 32 years of
age, all subjects from the original cohort were traced through the
Population Registry Centre in Finland and invited for a follow-up
assessment during 2006 to 2009. Of the 188 subjects who were
reached, 158 (84%) consented to participate and were examined at
the outpatient clinic at the Children’s Hospital, Helsinki University
Central Hospital, Finland. The reason for non-participation was
lack of time or interest. Subjects with known type 1 diabetes (n = 3)
were excluded from the present study, resulting in a study cohort
of 155 adults (74 males and 81 females) (Table 1).
Anthropometric measurements and body composition
At 32 years of age, all participants underwent a physical
examination and an interview by one of the authors (SP). At the
same visit, height to the closest 0.1 cm and weight to the closest
0.1 kg were measured in light clothing and without shoes. Body
mass index (BMI) was calculated as weight/height2 (kg/m2). Waist
circumference was measured to the closest 0.1 cm using a non-
elastic measuring tape. Blood pressure was measured after a 10-
minute rest, and the average of two measurements was used in the
analyses.
Biochemical markers
Venous blood was drawn after an overnight fast, and serum
samples were assessed for bone turnover markers: osteocalcin,
(EIA, The Roche Elecsys 1010/2010,Indianapolis, IN, USA),
procollagen type 1 N-terminal propeptide (P1NP) and carboxy-
terminal telopeptide of type I collagen (ICTP)(RIA, Orion
Diagnostica, Espoo, Finland) and serum insulin (immunofluoro-
metry). A second void urine sample was assessed for N-terminal
telopeptide urine collagen I aminoterminal telopeptide (NTX)
(EIA, Wampole Laboratories, Princeton, NJ, USA). In addition,
plasma glucose, cholesterol, HDL cholesterol, and triglycerides
were all measured using a photometric, enzymatic method (Roche
Diagnostics).
Bone mineral density and body composition
BMD for lumbar spine (LS), femoral neck (FN) and whole body
(WB) were measured using DXA (Hologic Discovery A, software
Figure 1. Associations between whole body bone mineral density (BMD), fat mass and lean mass in men (squares) and women
(triangles).
doi:10.1371/journal.pone.0108040.g001
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version 12.4:3, Waltham, MA, USA). Body composition, including
whole body fat and lean mass, was also assessed using DXA. The
coefficient of variation (CV) for BMD was 1.6–1.8% and for body
composition was 0.7–1.0% [14].
Covariates
Shared determinants for bone strength and cardiovascular risk
factors based on the literature were tested as potential confound-
ers. Many variables were dependent on gender, body size and fat
mass (Figure 1). Fat mass is expectedly higher with taller persons,
and therefore height was also used as a covariate. Lifestyle factors
(smoking, alcohol consumption and physical activity) modify both
bone remodelling and cardiovascular measures. These were
collected as reported earlier [9,11]. Lifestyle factors were coded
for analysis as follows: Physical activity from 1 to 5 (no exercise to
regular heavy training at least three times weekly); alcohol
consumption from 1 to 6 (no alcohol usage to daily usage).
Smoking was defined by the amount of cigarettes smoked per day.
Statistical analyses
Associations between individual bone and cardiovascular
measures were investigated using partial correlations. Four
additive models were constructed: gender (Model 1), + height
and fat mass (Model 2) and + lifestyle factors of smoking, physical
activity and alcohol consumption (Model 3) to explore possible
mediators. Continuous variables were used when available. A
student’s t test was used when comparing differences between two
groups (genders) and the chi-square test was utilised for categorised
variables. Characterisation of metabolic syndrome was based on
plasma glucose concentration, systolic and diastolic blood pres-
sure, HDL cholesterol and triglyceride concentrations, and waist
circumference according to the National Cholesterol Education
Program Adult Treatment Panel III (NCEP-ATPIII) [3].
Ultimately, multivariate analysis was carried out to evaluate
bone measures (BMD, BTMs) between healthy individuals (no-
MetS) and those fulfilling the criteria for metabolic syndrome
(MetS) [3]; in crude values and fully adjusted models ( = height, fat
mass and life-style factors). In the final analyses, we included only
men because of the interaction between gender and outcome
variables, and because only two women fulfilled the criteria for
metabolic syndrome. A P value of ,0.05 was considered
significant. All analyses were performed using IBM SPSS Statistics,
Version 19.0.
Results
Cohort characteristics
All anthropometrics were significantly higher in males com-
pared with females, as expected (Table 1). A higher proportion of
males were overweight as compared with females (50% vs. 25%,
P= 0.001). Fat percentage was higher in females (P,0.001), but
there was no difference in absolute fat mass between the genders.
The males had higher systolic and diastolic blood pressure than
females (P,0.001). Of the participants, 74% exercised at least
twice a week and their alcohol consumption was moderate, up to
twice a week in 88%. Altogether 69% did not smoke. However,
males smoked more often and consumed more alcohol than
females, while no difference was observed in physical activity
between the genders.
Males had higher levels of fasting plasma glucose and
triglycerides than females (Table 2), but the opposite was observed
in plasma HDL-cholesterol (P,0.001). BTMs did not differ
between the genders. In males, 12 out of 74 (16.2%) fulfilled the
criteria for metabolic syndrome according to NCEP-ATPIII,
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compared with 2 out of 81 (2.4%) of the females (P = 0.003)
(Table 3).
BMI correlated positively with BMD at all measured sites. The
detailed body composition assessed by DXA revealed that fat
percentage and fat mass had an inverse correlation with BMD,
whereas a positive correlation was observed between lean mass
and BMD (data not shown). The associations between whole body
BMD and body composition by gender are shown in Figure 1. In
males, an inverse association was found between whole body BMD
and fat mass (R=20.255, P= 0.027), but no correlation between
BMD and lean mass. In contrast, in females, BMD associated with
lean mass (R= 0.300, P= 0.007) but not with fat mass.
Correlations of bone turnover markers and BMD with the
characteristics of metabolic syndrome
The data on crude and adjusted partial correlation between
BTMs/BMD and the individual risk factors of CVD are presented
in Table 4. Bone formation markers, osteocalcin and P1NP,
correlated inversely with plasma glucose (R=20.21, P = 0.003;
R=20.19, P = 0.021) and with serum insulin levels (R=20.24,
P = 0.003; R=20.19, P= 0.021), respectively. The correlation
remained after adjustment for gender, height and fat mass, except
for P1NP and insulin, which was attenuated after controlling for
fat mass. In the fully adjusted model 3, including lifestyle factors,
the associations disappeared signifying that the association
between osteocalcin and glucose/insulin is mediated by lifestyle
factors.
Neither bone resorption markers (ICTP and urine NTX) nor
BMD (at FN, LS and WB) correlated with serum insulin levels
(Table 4). Urine NTX did not correlate with any of the individual
characteristics of metabolic syndrome. In contrast, plasma ICTP
showed a negative correlation with plasma glucose level in the
crude and adjusted models (R=20.189, P= 0.044).
LS BMD (R=0.160, P= 0.048) and FN BMD (R=0.197,
P = 0.014) correlated with waist circumference, and FN BMD
correlated with plasma HDL-cholesterol level (R=20.173,
P = 0.032) in the crude models. These correlations disappeared
after adjustment for gender. A negative correlation was uncovered
between FN BMD (R=20.167, P= 0.042) and LS BMD (R=2
0.185, P= 0.024) with plasma triglyceride level after adjustment
for fat mass. Correspondingly, an association between WB BMD
and plasma triglycerides emerged after controlling for gender
(R=20.228, P= 0.005) and remained after additional adjust-
ments for height (R=20.241, P= 0.003) and fat mass (R=2
0.210, P= 0.010) (Table 4). The correlation did not change after
additional adjustment for lifestyle factors.
Bone turnover markers/BMD and the presence of
metabolic syndrome
Using multivariate analysis, the differences in BTMs and BMD
were evaluated between healthy subjects (no-MetS) and those with
an increased risk of metabolic syndrome (MetS = NCEP ATPIII
criteria $3 present). Because of the interaction between gender
and the outcome variables, the analyses were performed separately
in men and women. In the end, the analysis was performed only in
men because of the low number (N= 2) of women fulfilling the
criteria for metabolic syndrome.
Crude analyses showed that the concentrations of P1NP and
osteocalcin were slightly higher in the no-MetS group compared
with the MetS group, (P = 0.051 and P= 0.089, respectively)
(Figure 2). The difference between the groups regarding P1NP
and osteocalcin was flattened after adjusting for fat mass (P = 0.50
and 0.22, respectively), proposing fat mass as a possible mediator.
After adjustment for lifestyle factors, the difference was attenuated
and modified regarding both bone formation markers (P = 0.82
and P= 0.36, respectively), which suggests that these covariates
mediate the association between bone formation and metabolic
syndrome. Other bone turnover markers did not differ between
participants with and without metabolic syndrome in any of the
models (Data not shown).
In crude analyses, whole body BMD tended to be lower in men
with MetS compared with those without MetS (P = 0.117). There
were no differences in other BMD sites (data not shown).
Adjustment for fat mass and height attenuated the difference
between the groups (P= 0.80), and again lifestyle factors further
modified the association, suggesting that these factors were
stronger determinants for BMD and metabolic syndrome
(P= 0.94) (Figure 2).
Discussion
We observed inverse associations between bone health and
individual risk factors of CVD in the present cross-sectional study:
low concentration of both bone formation markers, osteocalcin
and P1NP were accompanied with elevated fasting insulin and
glucose levels in healthy adults at 32 years of age. The final
analyses showed that men with metabolic syndrome had lower
P1NP concentrations compared with healthy subjects, and a
Table 3. Individuals beyond the cut-off limits contributing to metabolic syndrome according to the NCEP-ATPIII criteria [3].
ALL (N=155) Males (n=74) Females (N=81) Pa
N (%) N (%) N (%)
fP-Glucose .5.6 mmol/L 30 (19.5) 25 (33.8) 5 (6.3) ,0.001
fP-Triglycerides $1.7 mmol/L 11 (7.1) 9 (12.1) 2 (2.5) 0.027
fP-HDL #1.0*/1.3{ mmol/L 12 (7.8) 7 (9.5) 5 (6.3) 0.55
Waist circumference $102*/88{ cm 25 (16.2) 10 (13.5) 15 (18.8) 0.51
SBP .130 and/or DBP .85 mm Hg 38 (24.7) 31 (41.9) 7 (8.8) ,0.001
$3 NCEP-ATPIII criteria 14 (8.9) 12 (15.8) 2 (2.4) 0.003
Abbreviations: fP, fasting plasma; SBP, systolic blood pressure; DBP, diastolic blood pressure; NCEP-ATPIII, National Cholesterol Education Program Adult Treatment
Panel III.
aP values calculated between the genders using Chi-square test;
*male;
{female.
doi:10.1371/journal.pone.0108040.t003
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similar, but non-significant, trend was observed for osteocalcin.
Parallel, but non-significant, findings were seen for whole body
BMD, which was lower in men with metabolic syndrome than in
healthy men. Differences between the groups were attenuated
after adjustments for the confounders, emphasising the roles of fat
mass and lifestyle factors (physical activity, smoking and alcohol
consumption).
The role of osteocalcin in glucose metabolism and as a link
between bone and adipose tissue has been under active research.
In an animal model, osteocalcin deficiency was associated with
glucose intolerance, reduced insulin sensitivity and increased
adiposity [15]. Furthermore, the administration of recombinant
osteocalcin improved the measures of glucose and insulin
metabolism in wild-type animals [16]. Corresponding human
studies have been conducted mostly in patients with T2DM [17],
metabolic syndrome [18,19], coronary heart disease [18], osteo-
porosis therapy [20] or hypertension [19], and these have
witnessed low osteocalcin to associate with higher fasting plasma
insulin, glucose and triglyceride levels without proof of causality.
Studies assessing the role of osteocalcin in metabolically healthy
subjects are scarce. Polgreen et al. (2012) reported inverse
relationships between osteocalcin and BMI, waist circumference,
systolic blood pressure and insulin resistance in young healthy
adolescents and adults at a mean age of 19 years [21]. Their
findings were attenuated after further adjustments for BMI, also
suggesting that BMI was the mediator. Our findings are in
accordance with these observations, and confirm inverse associ-
ations between osteocalcin and risk factors of CVD in apparently
healthy young adults. Furthermore, we found that similar to
osteocalcin, P1NP correlated inversely with both glucose and
insulin. On the other hand, bone resorption markers were not
associated with any risk factors of CVD.
The aspect of whether or not body fat is beneficial for bone is
controversial. It has been generally accepted that overweight and
high BMI protect against osteoporosis. This might not apply to all
age groups, beyond the range of normal weight, or for both
genders [22–24]. The balance between bone formation and
resorption varies in childhood, in young adulthood and in
advanced age/elderly subjects, which might explain the contro-
versial results. Higher BMI was found to protect against
osteoporotic and other fractures, especially in lean subjects,
however, after controlling for BMD, the risk ratio became non-
significant in all BMI categories in a large meta-analysis of over
60,000 participants from 12 different prospective cohorts [25]. A
study on growing teenagers by Lawlor et al. reported a positive
association between fat mass and bone mass in adolescents aged 15
years, and concluded that the finding was not mediated through
fasting glucose or lipids [8]. In the present study, an inverse
association was observed between fat mass and BMD in males.
Corresponding results have been reported in other cohorts; Hsu
et al. [26] reported that higher fat percentage was associated with
lower bone mineral content (BMC) in Chinese men and women
aged 25–64 years. Confounders taken into account included
physical activity, weight and years from menopause. Similar to us,
they noticed that plasma lipids were also negatively associated with
BMC [26]. In another study, African-American female college
students from the USA with a high percentage body fat (.32%)
had lower cortical bone strength at 19 year of age than those with
a normal fat percentage [27]. Our findings suggest that excessive
fat contributes to metabolic disturbances such as insulin resistance,
elevated blood pressure and triglycerides, which initially appear to
be inversely related to skeletal parameters, at least in men. A
deeper examination revealed that these correlations were medi-
ated by fat mass and lifestyle factors. Thus, no associations were
left between bone and glucose metabolism after taking into
account fat mass, physical activity, smoking and alcohol
consumption. In addition, a deeper examination uncovered
Figure 2. Differences in whole body BMD, osteocalcin and
P1NP between healthy men (no-MetS) and those with meta-
bolic syndrome (MetS) (NCEP ATPIII.3), with crude values and
after adjusted for height (H) and fat mass (FM), and then
additionally adjusted separately for each lifestyle factor;
physical activity (PA), alcohol consumption and smoking and
final adjustment for all confounding factors (ALL).
doi:10.1371/journal.pone.0108040.g002
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independent risk factors for BMD of which triglycerides, but less
likely diastolic blood pressure, appeared consistently and inversely
related to BMD. In accordance with our finding, a Korean study
reported high triglyceride concentration to associate inversely with
femoral neck BMD after adjustments in men aged 48 years [7].
Metabolic syndrome comprises a cluster of risk factors for CVD,
and in the ultimate analysis we compared BTMs and BMDs
between men with vs. without metabolic syndrome. In crude
analyses, bone formation markers and WB BMD tended to be
lower in men with metabolic syndrome compared with those
without metabolic syndrome, but the differences were attenuated
by fat mass and lifestyle factors. Parallel to our findings, BMD was
lower in premenopausal and postmenopausal Korean women with
metabolic syndrome compared to those without metabolic
syndrome [5]. The explanation offered by Jeon et al. is the higher
inflammation status among those with metabolic syndrome, as
measured by C-reactive protein, suggesting that obesity and
metabolic syndrome maintain inflammation that activates bone
resorption [5]. We are not arguing with this explanation, but we
would like to know whether the association would remain after
adjusting for fat mass. In addition, smoking, excessive alcohol
consumption [28] and low physical activity [29] are all related to
an elevated risk of these non-communicative diseases. Later in life,
especially in women, diminishing levels of oestrogen impair bone
health and increase the risk of CVD. Nutritional habits can
influence the subsequent risk of developing metabolic syndrome,
and building and maintaining stronger bones.
No conclusion about causality between bone health and
metabolic syndrome could be drawn in our study. For that
purpose, follow-up studies are needed. Another limitation of our
study, related to the small study cohort that consisted of single age
group and young age of the subjects, was the low number of
women who fulfilled the criteria of metabolic syndrome, prohib-
iting analysis in women. In addition, it may be that our findings
cannot be generalised to other ethnic populations, as all of the
subjects were white Caucasians. However, the homogeneity of our
study population in respect of ethnicity, age and lack of
cardiovascular morbidity can be considered as strength. Further-
more, a DXA-derived assessment of body composition is a more
reliable measure of body adiposity than the generally used BMI or
weight. For bone health, we broadly used both BTMs and BMD to
evaluate the associations, and a wide range of potential
confounding factors were included in the analysis. Young
adulthood is a novel target group for studying the association
between bone health and risk of CVD while BMD is at its peak
level and the risk factors of CVD are emerging.
Our most important conclusion is that the inverse association
between bone formation markers (osteocalcin, P1NP) and fasting
glucose and insulin in our cohort of young adults was mediated
mainly by fat mass, while triglycerides remained, independently of
fat mass, inversely associated to BMD. Men with metabolic
syndrome had somewhat lower BTMs and WB BMD compared
with men without metabolic syndrome, but the differences
disappeared when fat mass was introduced: this reinforce the role
of fat mass as a mediator. Future studies in older age groups are
warranted to confirm our findings. Especially prospective studies
are needed to further study the pathophysiology between CVD
and osteoporosis, to address the causal relationships between bone
and energy metabolism and to specify the role of mediators,
lifestyle factors, in the prevention of osteoporosis and CVD.
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